Primary Site >> Liver Cancer
Gene >> FGFR2
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|
|
Ref: Expressions of basic fibroblast growth factor and its receptors and their relationship to proliferation of human hepatocellular carcinoma cell lines. PMID: 8707262 |
Ref: Emodin regulating excision repair cross-complementation group 1 through fibroblast growth factor receptor 2 signaling. PMID: 23674849 Ref: The fibroblast growth factor receptor 2-mediated extracellular signal-regulated kinase 1/2 signaling pathway plays is important in regulating excision repair cross-complementary gene 1 expression in hepatocellular carcinoma. PMID: 24648994 |
Ref: Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma. PMID: 24122810 Ref: Identification of latent biomarkers in hepatocellular carcinoma by ultra-deep whole-transcriptome sequencing. PMID: 24141781 Ref: New routes to targeted therapy of intrahepatic cholangiocarcinomas revealed by next-generation sequencing. PMID: 24563076 Ref: A preclinical evaluation of a novel multikinase inhibitor, SKLB-329, as a therapeutic agent against hepatocellular carcinoma. PMID: 24789676 Ref: Inhibition of fibroblast growth factor receptor signaling impairs metastasis of hepatocellular carcinoma. PMID: 25091573 |
Ref: Massive parallel sequencing uncovers actionable FGFR2-PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma. PMID: 25608663 Ref: Fibroblast growth factor receptor isotype expression and its association with overall survival in patients with hepatocellular carcinoma. PMID: 25834803 Ref: Targeting FGFR Pathway in Human Hepatocellular Carcinoma: Expressing pFGFR and pMET for Antitumor Activity. PMID: 26351320 |
Ref: Molecular subclasses of hepatocellular carcinoma predict sensitivity to fibroblast growth factor receptor inhibition. PMID: 26481559 Ref: The landscape of targeted therapies for cholangiocarcinoma: current status and emerging targets. PMID: 27102149 Ref: Genomic characterization of liver metastases from colorectal cancer patients. PMID: 27662660 |
Ref: SNORD126 promotes HCC and CRC cell growth by activating the PI3K-AKT pathway through FGFR2. PMID: 27913571 Ref: An investigation of the role of gene copy number variations in sorafenib sensitivity in metastatic hepatocellular carcinoma patients. PMID: 28382134 Ref: Prognostic role of fibroblast growth factor receptor 2 in human solid tumors: A systematic review and meta-analysis. PMID: 28618942 |
Ref: Novel targeted therapy strategies for biliary tract cancers and hepatocellular carcinoma. PMID: 29460642 Ref: Low-level clonal FGFR2 amplification defines a unique molecular subtype of intrahepatic cholangiocarcinoma in a Chinese population. PMID: 29514108 Ref: Deep sequencing of human papillomavirus positive loco-regionally advanced oropharyngeal squamous cell carcinomas reveals novel mutational signature. PMID: 29879932 Ref: FGFR3 mRNA overexpression defines a subset of oligometastatic colorectal cancers with worse prognosis. PMID: 30181810 |